Didier Adiko
Libourne, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 07, 2022
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.
Journal: Cancer medicine
Published: March 01, 2021
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.
Journal: Cancers
Published: August 05, 2020
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.
Journal: European journal of haematology
Published: April 19, 2018
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study.
Journal: American journal of hematology
Published: December 07, 2017
ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?
Journal: American journal of hematology
Published: October 01, 2014
Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy.
Journal: Haematologica
Published: December 24, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026